Keyphrases
Ventricular Dysfunction
100%
Dilated Cardiomyopathy
100%
Carvedilol
100%
Ejection Fraction
83%
Pediatric Patients
33%
Clinical Change
33%
Maximal Medical Therapy
16%
Adverse Events
16%
Maximum Tolerated Dose
16%
Heart Failure
16%
Academic Medical Centers
16%
Am(III)
16%
Kaplan-Meier Analysis
16%
ACE Inhibitors
16%
Time Since Death
16%
Drug Trials
16%
Weight Fraction
16%
Echocardiographic Parameters
16%
Safety Committee
16%
Historical Controls
16%
Composite Endpoint
16%
Entry Criteria
16%
Systemic Ventricle
16%
Improved Ejection Fraction
16%
Medicine and Dentistry
Arm
100%
Heart Ventricle Function
100%
Ejection Fraction
100%
Dilated Cardiomyopathy
100%
Carvedilol
100%
Transplantation
33%
Pediatrics Patient
33%
Adverse Event
16%
Combination Therapy
16%
Heart Failure
16%
Kaplan Meier Method
16%
Ventricle of Heart
16%
Drug Screening
16%
ACE Inhibitor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Cardiomyopathy
100%
Carvedilol
100%
Combination Therapy
16%
Adverse Event
16%
Maximum Tolerated Dose
16%
Heart Failure
16%
Dipeptidyl Carboxypeptidase Inhibitor
16%
Drug Screening
16%